Leeward Investments LLC MA Cuts Position in Cabot Co. (NYSE:CBT)

Leeward Investments LLC MA trimmed its holdings in shares of Cabot Co. (NYSE:CBT) by 0.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 172,190 shares of the specialty chemicals company’s stock after selling 650 shares during the quarter. Leeward Investments LLC MA’s holdings in Cabot were worth $19,246,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. BNP Paribas Financial Markets grew its stake in Cabot by 28.8% in the 1st quarter. BNP Paribas Financial Markets now owns 51,271 shares of the specialty chemicals company’s stock valued at $4,727,000 after purchasing an additional 11,471 shares during the period. Janney Montgomery Scott LLC increased its holdings in Cabot by 125.4% during the first quarter. Janney Montgomery Scott LLC now owns 10,911 shares of the specialty chemicals company’s stock worth $1,006,000 after buying an additional 6,070 shares during the last quarter. Sei Investments Co. raised its position in Cabot by 6.1% in the first quarter. Sei Investments Co. now owns 862,081 shares of the specialty chemicals company’s stock worth $79,484,000 after acquiring an additional 49,467 shares during the period. Assenagon Asset Management S.A. boosted its stake in Cabot by 571.9% in the second quarter. Assenagon Asset Management S.A. now owns 127,116 shares of the specialty chemicals company’s stock valued at $11,681,000 after acquiring an additional 108,197 shares during the last quarter. Finally, Tidal Investments LLC grew its position in shares of Cabot by 101.7% during the 1st quarter. Tidal Investments LLC now owns 18,107 shares of the specialty chemicals company’s stock valued at $1,669,000 after acquiring an additional 9,131 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Trading Up 7.5 %

Shares of CBT stock opened at $117.02 on Thursday. The stock has a market capitalization of $6.42 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 0.91 and a beta of 1.20. The company’s fifty day simple moving average is $108.69 and its two-hundred day simple moving average is $101.24. Cabot Co. has a 1 year low of $68.11 and a 1 year high of $117.37. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1.01 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period last year, the company posted $1.65 EPS. As a group, analysts anticipate that Cabot Co. will post 7.07 earnings per share for the current year.

Insider Activity at Cabot

In other news, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now directly owns 331,174 shares in the company, valued at $33,630,719.70. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, EVP Hobart Kalkstein sold 5,457 shares of Cabot stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total transaction of $548,865.06. Following the completion of the sale, the executive vice president now owns 61,688 shares in the company, valued at approximately $6,204,579.04. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now owns 331,174 shares in the company, valued at approximately $33,630,719.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 48,665 shares of company stock valued at $4,986,299. Corporate insiders own 3.07% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. UBS Group dropped their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Finally, Mizuho increased their price target on Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $105.00.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.